Napo Pharmaceuticals seeks orphan drug designation for Mytesi to treat diarrhea in breast cancer patients with brain metastases undergoing targeted therapy. Mytesi, a plant-based drug, restores gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results